Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. - Wikidata - awgldk - TriplyDB

Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.

Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.

http://www.wikidata.org/entity/Q34552993

about

Anaplastic lymphoma kinase: signalling in development and disease Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis Netrin-1 acts as a survival factor for aggressive neuroblastoma Receptor tyrosine kinases in the nucleus Emerging importance of ALK in neuroblastoma FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase Molecular pathogenesis of peripheral neuroblastic tumors ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation A multi-factor model for caspase degradome prediction Interfering with multimerization of netrin-1 receptors triggers tumor cell death.ALK-rearrangements and testing methods in non-small cell lung cancer: a review Dependence receptor TrkC is a putative colon cancer tumor suppressor.Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression.The Drosophila midkine/pleiotrophin homologues Miple1 and Miple2 affect adult lifespan but are dispensable for alk signaling during embryonic gut formation.Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action Dependence receptors: mechanisms of an announced death.Anaplastic lymphoma kinase is expressed in different subtypes of human breast cancer.ALK-immunoreactive neoplasms.Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology The shadow of death on the MET tyrosine kinase receptor.Anaplastic lymphoma kinase-positive large B-cell lymphoma: a distinct clinicopathological entity Trafficking of receptor tyrosine kinases to the nucleus Targeting neurotrophin-3 and its dependence receptor tyrosine kinase receptor C: a new antitumoral strategy.Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.Anaplastic lymphoma kinase as a therapeutic target.Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond.Peptides derived from the dependence receptor ALK are proapoptotic for ALK-positive tumors.Successful Preservation of the Bladder in a Case of Inflammatory Myofibroblastic Tumor with the Diagnostic Efficacy of ALK/p80 Immunohistochemistry and FISH Analysis: Case Report and Review of the Literature.The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking.Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines.NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases.

P2860

Q24312329-2E7B6186-91EF-4F5E-866A-E5B4CC6C0BBF Q24336817-B4F893BA-92FF-4076-89AC-89E178AD9548 Q24642741-3C1B2033-3933-47E6-B659-4174A5ED65D5 Q24645254-54E76FCA-3554-48ED-83BE-8A1FE4C9C881 Q26830216-AA992CE4-2DBB-4806-B7E6-C27B3A05EB04 Q26858819-15549CDA-8EA6-4F8B-88E4-7B1B00A66469 Q28118071-83584002-2933-4ECD-9BE8-F41455B733DA Q28271405-3DF548FA-DAC0-497C-BD76-D1D46006830D Q28564190-F35515D5-C2A6-4DF7-9335-382474148D41 Q30951290-B9E48313-43B7-4583-BA94-D7E1487BDF79 Q33739093-7447286B-975E-4A63-A5E6-BB82FBBADEB2 Q33776835-87769C8E-F719-4393-B41F-7B592ACF3989 Q34323861-238CF638-EAD1-4892-897D-1698D48E664D Q34351731-115B5A59-370A-41A5-8BE7-E7C048CE41B7 Q34473183-719BED7C-51B5-42F8-930C-D489058760C5 Q35092693-43D941DC-ACEE-464A-A6AE-D64936B05FEC Q35887831-FBCB42B3-3638-4CB0-9DE0-3A57C848EAD6 Q35933411-969C0D57-5AB6-4D7F-B29F-90F037B4F310 Q36092957-B8389E00-A656-47D9-BA2D-B5166A877137 Q36405628-0E8A2144-6089-4943-BF09-B999464401B7 Q36961606-0C6EE3B3-3A64-43E1-A756-E37270AA9CFC Q37268913-58B1C6C6-0EB6-4719-96CD-DB3970898341 Q37308472-6227C088-0992-40C1-90D5-1A19AED2F844 Q37862753-58B23722-3FF7-4450-93EC-58278A5556B7 Q38042570-9F1A255A-D191-4C87-8661-C8642B305B9D Q38045455-13C4891E-BF21-449C-8405-35BC375971EA Q38207137-96060F9F-58FB-401C-8DBB-F5573265BBD1 Q38307616-47C8B351-DAD9-43A5-BD31-C1DF113EDE9F Q38461723-8D32762B-05A7-454B-8543-FC0A7E963EC8 Q38878195-5FAE723F-FC8A-4806-9541-DEC927143474 Q39084856-7EE39775-C643-4DFA-AB85-C73F57588CB5 Q39606679-12D1602B-4046-4581-A9C5-7475D8196208 Q39800101-E4F279D6-70CE-4566-A339-D3E65C136FBE Q42254184-C6E70CAD-CCB8-40CF-B0B1-9BACD0C6E0D3

P2860

Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.

http://www.wikidata.org/entity/Q34552993

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Anaplastic lymphoma kinase is ...... activated by caspase cleavage.

@ast

Anaplastic lymphoma kinase is ...... activated by caspase cleavage.

@en

Anaplastic lymphoma kinase is ...... activated by caspase cleavage.

@nl

type

label

Anaplastic lymphoma kinase is ...... activated by caspase cleavage.

@ast

Anaplastic lymphoma kinase is ...... activated by caspase cleavage.

@en

Anaplastic lymphoma kinase is ...... activated by caspase cleavage.

@nl

prefLabel

Anaplastic lymphoma kinase is ...... activated by caspase cleavage.

@ast

Anaplastic lymphoma kinase is ...... activated by caspase cleavage.

@en

Anaplastic lymphoma kinase is ...... activated by caspase cleavage.

@nl

P1433

Q34552993-D166E773-17C9-4F71-98CD-BDBE1C725D54

P1476

Q34552993-DA85A664-BF05-462D-AD08-6DDEAE96B2C7

P2093

Q34552993-124CB71B-7C62-4208-A581-0FA70D590B17

Q34552993-32850549-6864-49AA-97EE-6B2949733544

Q34552993-470B9E09-9DAA-44BA-8A9A-EAD23743C5F8

Q34552993-55916C45-B917-4D92-9C07-94259B1314BA

Q34552993-5F5CA70A-F548-451E-BF49-8A71CBB8011E

Q34552993-C3016108-5BE6-4BB1-BE58-07D29B0BA958

Q34552993-CB52C547-A724-40F9-ADF3-AA5156154B52

Q34552993-D4D7CA7D-F822-4970-A468-7F03B5869FF6

P2860

Q34552993-0664B4D0-ADB6-47F1-9847-6E8ABCF39672

Q34552993-09535DC4-8A8B-4C29-8C20-BE5E840EA730

Q34552993-0D6BE41D-E55E-4D33-A48C-54CDCAFD53B9

Q34552993-11D6BFE4-F61D-4250-944E-E513A237C9CE

Q34552993-25296862-E3B9-464D-A0AC-11260FF7EACF

Q34552993-29170B1A-D3EA-4B58-B063-B64BB8615FFE

Q34552993-29987E20-6F08-4AA3-8A19-5F1B777B28C2

Q34552993-32900F74-5353-417E-9377-CD434D714D67

Q34552993-32CF7DF2-36F3-4C50-BED8-F18AFD01D029

Q34552993-331ABAD0-E953-443E-9F0F-CBF1AECBC3AC

P304

Q34552993-E8BF24C4-7389-40E6-9E10-089458625469

P31

Q34552993-3DF78006-9EB3-4CDC-835D-AFF38DF0943A

P356

Q34552993-D93BCA10-2493-49E6-8014-7EFD3E8F6120

P407

Q34552993-09DA8749-61D1-4C65-9DA5-1E516DBE07A5

P433

Q34552993-B482A8E0-EB37-4B63-AAB1-779D08BDD624

P478

Q34552993-8D7AEF9B-1573-4977-A781-A596AE78F065

P50

Q34552993-25D66162-DA48-4F0A-96F4-5A4BA796E112

Q34552993-287DE51D-3BB7-4591-B69D-DC9F8A168823

Q34552993-DAD8627B-8796-4609-810D-4CB1C66B0B04

Q34552993-E2ABF7E4-370A-4ED6-B4A5-5E0FE8542B85

P577

Q34552993-3EB739F3-B6D1-45C6-83CF-D6CE16EFA695

P698

Q34552993-61C3FECA-0B24-42B4-B8D4-15025A754748

P932

Q34552993-C822A8D8-E4B5-4DC7-938F-4386DF374EF1

P356

P1433

Molecular and Cellular Biology

P1476

Anaplastic lymphoma kinase is ...... activated by caspase cleavage

@en

P2093

Alan Bénard

http://www.w3.org/2001/XMLSchema#string

Catherine Greenland

http://www.w3.org/2001/XMLSchema#string

Christel Moog-Lutz

http://www.w3.org/2001/XMLSchema#string

Georges Delsol

http://www.w3.org/2001/XMLSchema#string

Jaouhar Mourali

http://www.w3.org/2001/XMLSchema#string

Marc Vigny

http://www.w3.org/2001/XMLSchema#string

Michèle Allouche

http://www.w3.org/2001/XMLSchema#string

Patrick Mehlen

http://www.w3.org/2001/XMLSchema#string

P2860

The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity

The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation

Cell signaling by receptor tyrosine kinases

Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines

Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types

P304

6209-6222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MCB.01515-05

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Filipe C Lourenco

Daniel Gonzalez-Dunia

C Racaud-Sultan

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16880530

http://www.w3.org/2001/XMLSchema#string

P932

1592804

http://www.w3.org/2001/XMLSchema#string